March 21, 2018 / 3:43 AM / a month ago

BRIEF-Alembic Pharmaceuticals Says U.S FDA Issued 3 Observations For Panelav Formulation Facility

March 21 (Reuters) - Alembic Pharmaceuticals Ltd:

* SAYS U.S FDA CONDUCTED INSPECTION AT FORMULATION FACILITY AT PANELAV FROM 12 MARCH, 2018 TO 20 MARCH, 2018

* SAYS NONE OF OBSERVATIONS ARE RELATED TO DATA INTEGRITY OR REPETITIVE IN NATURE

* WAS SCHEDULED INSPECTION AND AT END OF INSPECTION, US FDA ISSUED A FORM 483 WITH 3 OBSERVATIONS

* SAYS COMPANY IS PREPARING RESPONSE TO OBSERVATIONS Source text -bit.ly/2GPhwlN Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below